Study of antibodies in Babies born to mothers who are recovered from COVID 19
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: O989- Unspecified maternal infectious and parasitic disease complicating pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2021/06/034057
- Lead Sponsor
- Sparsh Hospital Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All pregnant women who are infected with COVID 19 during the gestation period
Exclusion Criteria
NA
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To study the rate of transmission of maternal COVID Ig G antibodies to the neonate. <br/ ><br>2.To study the trend of maternally transmitted COVID Ig G antibodies in the neonate over the first seventy five days of life. <br/ ><br>Timepoint: first 75 days after the birth in a newborn. <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.To study the correlation of the COVID Ig G antibody levels to the duration since confirmed disease. <br/ ><br>2. To study the correlation of the COVID Ig G levels to the severity of the covid disease. <br/ ><br>3. To study the correlation of COVID Ig G levels to the duration since vaccination and the type of COVID vaccine used. <br/ ><br>4. To study the correlation of COVID Ig G levels to the interval between vaccine doses. <br/ ><br> <br/ ><br>Timepoint: follow up time till 75 Days after the delivery